TriSalus Life Sciences Inc. Earnings
The next earnings date for TriSalus Life Sciences Inc. is November 12, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of TriSalus Life Sciences Inc. Earnings
| 11/12/2026 | $-0.12 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
TriSalus Life Sciences Inc. Earnings: Historical
| 08/06/2026 | After Market | $-0.16 | -6.67% |
| 05/13/2026 | --- | $0.03 | 118.38% |
| 03/05/2026 | After Market | $-0.05 | 61.54% |
| 11/13/2025 | After Market | $-0.87 | -443.75% |
| 08/12/2025 | After Market | $-0.23 | -4.55% |
| 05/15/2025 | Before Market | $-0.33 | -65.00% |
| 03/27/2025 | --- | $-0.40 | -14.29% |
| 11/14/2024 | Before Market | $-0.40 | -11.11% |
| 08/14/2024 | After Market | $-0.21 | 54.35% |
| 05/15/2024 | Before Market | $-0.60 | 16.67% |
More About TriSalus Life Sciences Inc.
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.
“TriSalus Life Sciences Inc. Earnings” Can Refer to the TriSalus Life Sciences Inc. Earnings Date
Some people say “TriSalus Life Sciences Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my TriSalus Life Sciences Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning TriSalus Life Sciences Inc. Stock on the Earnings Date
If you own TriSalus Life Sciences Inc. stock (TLSI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for TriSalus Life Sciences Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading TriSalus Life Sciences Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More TriSalus Life Sciences Inc. Earnings
You can contact us any time if you would like to ask questions about TriSalus Life Sciences Inc. earnings or anything else related to the stock market.